Antiperoxidant effects of dihydropyridine calcium antagonists.
Janero
D R
DR
Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110.
Burghardt
B
B
D000818:Animals; D000975:Antioxidants; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D004095:Dihydropyridines / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects*; D008054:Lipid Peroxides / Q000096:biosynthesis; D009206:Myocardium / Q000201:enzymology / Q000378:metabolism*; D015737:Nisoldipine / Q000494:pharmacology; D010743:Phospholipids / Q000378:metabolism; D051381:Rats; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors
D000975:Antioxidants; D002121:Calcium Channel Blockers; D004095:Dihydropyridines; D008054:Lipid Peroxides; D010743:Phospholipids; D015737:Nisoldipine; D014969:Xanthine Oxidase